Browsing Tag

Market Watch

87 posts

Injectable Drugs: CDMOs/CMOs and Suppliers Expand
By

By
Injectable drugs are assuming a larger role in recent drug approvals and drug development owing to the increase in biologic-based drug development and complexity of APIs, which make injectable delivery…

The Top 10 Deals for Pharma Innovation
By

By
Which pharma/biopharma companies are drawing the attention of investors and the pharmaceutical majors? What companies are pursuing novel approaches in drug development, and what products are gaining attention? DCAT Value…

Pandemic Complicates an Already Challenging Outlook for the Global Pharma Industry 
By

By
The COVID-19 pandemic has greatly complicated an already challenging outlook for the global pharmaceutical industry. Graham Lewis, Vice President, Global Pharma Strategy, IQVIA lays out sales, cost, and supply impacts…

Market Watch: Dosage-Form Development and Manufacturing
By

By
Formulation and drug-delivery technologies play an important role in new product development, both in formulations with new active pharmaceutical ingredients (APIs) and in new routes of administration for existing APIs.…

Tracking Expansions in High-Potency Manufacturing
By

By
Driven by growth in oncology drugs, high-potency manufacturing is an active area of investment by CDMOs/CMOs. Which CDMOs/CMOs are making investments? DCAT Value Chain Insights rounds up key recent expansions…

Oncology Pharma Market: Immunotherapies on the Rise
By

By
Immunotherapies represent a growing sector in the global oncology pharmaceutical market. Now led by Merck & Co.’s Keytruda (pembrolizumab) and Bristol-Myers Squibb’s Opdivo (nivolumab), immunotherapies by Roche and AstraZeneca are…

Industry Scorecard: New Drug Approvals and Blockbusters
By

By
Is the blockbuster model still in play or has the paradigm to more specialized drugs and smaller patient populations narrowed the blockbuster field? DCAT Value Chain Insights looks at which drugs,…

Supplying Potential COVID-19 Treatments and Vaccines
By

By
The race is on to develop treatments and vaccines against COVID-19, and so is the need to assure supply of these potential drugs and vaccines. Pharma companies are leveraging their…

COVID-19’s Impact on Global Pharma Supply Chains
By

By
In the wake of COVID-19, industry groups, including the Pharmaceutical Research and Manufacturers of America and the Association of Accessible Medicines, are raising concerns over reduced availability of international air…

The Race for a Vaccine Against the Novel Coronavirus
By

By
Johnson & Johnson reported this week that it expects its lead vaccine candidate against the novel coronavirus (COVID-19) to enter clinical trials in September and outlined a manufacturing plan. Sanofi,…